Emese Zsiros

Associate Professor of Oncology

Roswell Park Comprehensive Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Fernando A. Angarita

University of Toronto

CANADA

View details

Austin Miller

Asst Professor of Oncology, Biostatistics and Bioinformatics

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Mark Long

Assistant Professor of Oncology

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Cheryl Chiang

Lausanne University Hospital (CHUV)

SWITZERLAND

View details

Sarah Lynam

Assistant Professor - Gynecologic Oncology

University Hospital

UNITED STATES

View details

Lisa Barroilhet

University of Wisconsin-Madison Carbone Cancer Center

UNITED STATES

View details

Kevin Eng

Research Assistant Professor

State University of New York at Buffalo

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emese Zsiros

Research Interests

Explore related searches

Contact this professor

Articles (10)

Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)

Whole-Genome Sequencing Identifies <i>PPARGC1A</i> as a Putative Modifier of Cancer Risk in <i>BRCA1/2</i> Mutation Carriers

Túlbizonyítás mint az igazságkeresés egy anomáliája a büntetőeljárásban

Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer (npj Vaccines, (2021), 6, 1, (36), 10.1038/s41541-021-00297-5)

Efficacy and Safety of Pembrolizumab in Combination with Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer: A Phase 2 Nonrandomized Clinical Trial

Mechanisms driving neutrophil-induced t-cell immunoparalysis in ovarian cancer

Ovarian cancer, version 2.2020

Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer

Abundance of regulatory t cell (Treg) as a predictive biomarker for neoadjuvant chemotherapy in triple-negative breast cancer

Microbiome and cancer immunotherapy

Collaborators (7)

Fernando A. Angarita

Austin Miller

Mark Long

Cheryl Chiang

Sarah Lynam

Lisa Barroilhet

Kevin Eng

Make your next move.